
Hartwig Medical Database
- Algorithms
- Billing code
- Biomarker
- Cancer of Unknown Primary
- cfDNA
- DNA
- Education
- End of Treatment
- GENAYA project
- Hartwig Medical Database
- Hartwig Medical Foundation
- Innovation
- IT
- Lab process
- Learning healthcare system
- Molecular diagnostics
- OncoAct
- Participating hospitals
- Patients' stories
- Personalized treatment
- Quality
- Rare cancers
- Re-use data
- Research
- Scientific publications
- Uncategorized
- Whole genome sequencing
- Working in the cloud

Clinical Trials Day and the importance of structurally recording treatment outcomes
Today, on Clinical Trials Day (May 20), we reflect on the importance of clinical research. For Hartwig, it’s a opportunity …

The viral landscape in metastatic solid cancers
Researchers from Norwegian University of Science and Technology and colleagues have recently systematically catalogued the presence of viral DNA (and …

Ten years of Hartwig Medical Foundation: a retrospect and a glimpse of the future
In its first decade, Hartwig Medical Foundation has made significant progress towards its goal of providing access to all diagnostic …

Clinical Cancer Genomics 2025: a cheerful boost for this rapidly emerging field
The atmosphere is buzzing, the excitement is almost tangible. This first Clinical Cancer Genomics Congress feels like an event that …

The Importance of Analyzing the DNA of Rare Tumors
One in four patients has a cancer type that is considered rare, meaning it occurs in fewer than six out …

To study rare cancers, collaboration is key
In honor of Rare Disease Day on February 28th, we spoke with Professor Stefan Fröhling about his research on rare …

Healthcare providers share insights about GENAYA for young adult cancer patients
In a series of short videos, our specialists share their insights on the GENAYA project. They explain what GENAYA is, …

Predicting therapy success based on gene expression
In addition to Whole Genome Sequencing of DNA, Hartwig Medical Foundation performs Whole Transcriptome Sequencing of RNA. Researcher Marjolein Lansbergen …

Pay attention to the ethical aspects of data sharing
Frank van Wijck, science journalist Eline Bunnik is an associate professor at the Department of Medical Ethics, Philosophy and History of …

Warnyta Minnaard represents patient interests and possibilities
Frank van Wijck, science journalist Warnyta Minnaard has been a member of Hartwig Medical Foundation’s Data Access Board (DAB) since February …

The starting point – always the patient
Frank van Wijck, science journalist Ele Visser is handing over his position as chairman of Hartwig Medical Foundation’s Data Access Board …

As chair of the DAB, Mariska Kool will take a helicopter view
Frank van Wijck, science journalist After the departure of Ele Visser, lawyer Mariska Kool from The Data Lawyers took over …
Blogs

Cancer, a rare disease?
It may come as a surprise to many on this International Rare Disease Day (February 28), that a significant number …
Read more
The complete DNA test is an important step toward treating forms of cancer that currently cannot be treated with targeted drugs.